References
- Eye Bank Association of America. Eye Bank Association of America Annual. Report: 1987–1988, 1988; 9, (5); insert.Foresight
- Alldredge O C, Krachmer J H. Clinical types of corneal transplant rejection: their manifestations, frequency, preoperative correlates, and treatment. Arch Ophthalmol 1981; 99: 599–604
- Fine M, Stein M. The role of corneal vascularization in human corneal graft rejection. Corneal Failure, B R Jones. Ciba Foundation Symposium 15, New Series, Associated Scientific Publ, Amsterdam 1973; 193–208
- Boisjoly H M, Tourigny R, Bazin R, Laughrea P A, Dube I, Chamberland G, et al. Risk factors of corneal graft failure. Ophthalmology 1993; 100: 1728–1735
- Maguire M G, Stark W J, Gottsch J D, Stulting R D, Sugar A, Fink N E, Schwartz A. Risk factors for corneal graft failure and rejection in the collaborative corneal transplantation studies. Ophthalmology 1994; 101: 1536–1547
- Vail A, Gore S M, Bradkey B A, Easty D L, Rogers C A. Corneal graft survival and visual outcome. Ophthalmology 1994; 101: 120–127
- Brown S I, Bloomfield S E, Pearce D B. A follow-up report on transplantation of the alkali-burned cornea. Am J Ophthalmol 1973; 77: 538–542
- Khodadoust A A, Abizadeh A. The fate of corneal regrafts after previous rejection reaction. Immunology and Immunopathology of the Eye, A M Silverstein, G R O'Conner. Masson, New York 1970; 167–173
- Borel J F, Feurer C, Gubler H U, Stahelin H. Biological effects of cyclosporin A: a new antilymphocytic agent. Agents Actions 1976; 6: 468–475
- Hess A D, Esa A H, Colombani P M. Mechanism of action of cyclosporine: effects on cells of the immune system and on subcellular events in T cell activation. Transplant Proc 1988; 20(No 2, Suppl 2)29–40
- Gluckman E, Devergie A, Lokiec F. Use of cyclosporine for the prevention of graft-versus host disease after allogenic bone marrow transplantation. Transplant Proc 1988; 20(No 3, Suppl 3)461–469
- Berlin M W, Bouchard C S, Franz S, Chmielinska J. Topical cyclosporine in high-risk corneal transplants. Ophthalmology 1989; 96: 1144–1150
- Williams K A, Erickson S A, Coster D J. Topical steroid, cyclosporin A, and the outcome of rat corneal allografts. Br J Ophthalmol 1987; 71: 239–242
- Hill J C. The use of cyclosporine in high-risk keratoplasty. Am J Ophthalmol 1989; 107: 506–510
- Hill J C. Systemic cyclosporine in high-risk keratoplasty. Short-versus long-term therapy. Ophthalmology 1994; 101: 128–133
- Uusitalo R, Mahlberg K, Dua H, Donodo K, Gomes J AP, Oksala O. Cyclosporin A in high risk keratoplasty. Experimental and clinical data. Third Int Symp on Ocular Inflammation. 22–25 Ocotber. FukuokaJapan 1994; 43
- Kruit P L, Van Balen A ThM, Stilma J S. Cyclosporin A treatment in two cases of corneal peripheral melting syndrome. Doc Ophthalmol 1985; 59: 33–39
- Masuda K, Nakajima A. A doublemasked study of cyclosporin treatment in Behcet's disease. Cyclosporin in Autoimmune Diseases. 1st Int Symp, Basel, March 18–20, R Schindler. Springer-Verlag, Berlin 1985; 162–164
- Nussenblatt R P, Palestine A G, Rook A H, Scher I, Wacker W B, Gery I. Treatment of intraocular inflammatory disease with cyclosporin A. Lancet 1983; 2: 235–238
- BenEzra D, Cohen E, Rakatomalala M, de Courten C, Harris W, Chajek T, et al. Treatment of endogenous uveitis with cyclosporin A. Transplant Proc 1988; 20(No 3, Suppl 4)122–127
- Vine W, Billiar T, Simmons R, Bowers L D. Cyclosporine-induced hepatotoxicity: a microassay by hepatocytes in tissue culture. Transplant Proc 1988; 20(No 3, Suppl 3)859–862
- Palestine A G, Austin H A., III, Balow J E, Antonovych T T, Sabnis S G, Preuss H G, Nussenblatt R B. Renal histopathologic alternations in patients treated with cyclosporin for uveitis. N Engl J Med 1986; 314: 1293–1298
- Mihatsch M J, Thiel G, Ryffel B. Histopathology of cyclosporine nephrotoxicity. Transplant Proc 1988; 20(No 3, Suppl 3)759–771
- Goichot-Bonnat L, Chemal P, Pouligney Y. Cyclosporine A collyre dans la prévention du rejet de greffe de cornée à haut risque. II. Résultats cliniques post-opératoires. J Fr Ophtalmol 1987; 10: 213–217
- Head J F, Elliott R L, McCoy J L. Evaluation of lymphocyte immunity in breast cancer patients. Breast Cancer Res Treat 1993; 26: 77–88
- Mahlberg K, Uusitalo R J, Gebhardt B, Kaufman H E. Prevention of experimental corneal allograft rejection in rabbits using cyclosporin collagen shields. Graefe's Arch Clin Exp Ophthalmol 1991; 229: 69–74